Every antibiotic class in Lecture 1, with whether it covers gram-positives, gram-negatives and anaerobes — taken from the traffic-light table on each class slide. 26 classes: 8 lean gram-positive, 4 lean gram-negative, 13 cover both equally.
| Class & drugs | Gram + | Gram − | Anaerobes | Leans | What that means | Slide |
|---|---|---|---|---|---|---|
| Natural penicillinspenicillin G, penicillin V | covers | no | partial | Mainly gram-positive | Good against gram-positive cocci, but no staph coverage. Drug of choice for syphilis, gas gangrene and meningococcus. No activity against aerobic gram-negatives. | 17 |
| Aminopenicillinsampicillin, amoxicillin | covers | no | partial | Mainly gram-positive | As the natural penicillins, plus some gram-negative aerobes. Drug of choice for Enterococcus, Listeria and endocarditis prophylaxis. Still no staph coverage. | 19 |
| Aminopenicillin + beta-lactamase inhibitoramoxicillin/clavulanate, ampicillin/sulbactam | covers | partial | covers | Mainly gram-positive | Adding the inhibitor buys anaerobes (including Bacteroides) and MSSA. Drug of choice for skin and soft tissue, diabetic foot, and animal or human bites. | 25 |
| Penicillinase-resistant penicillinsnafcillin, oxacillin, dicloxacillin | covers | no | no | Mainly gram-positive | Designed solely to cover S. aureus (MSSA), with decreased activity against everything else. Not for MRSA — vancomycin is the choice there. | 26 |
| Antipseudomonal penicillinspiperacillin, piperacillin/tazobactam | covers | covers | covers | Both equally | Broad spectrum. Keeps gram-positive coverage (MSSA only), adds gram-negative and antipseudomonal activity. Drug of choice for polymicrobial, nosocomial and intra-abdominal infection. | 27 |
| Cephalosporins — 1st generationcefazolin, cephalexin | covers | partial | no | Mainly gram-positive | Great gram-positive activity (but no Enterococcus). Some gram-negatives — E. coli, Proteus, Klebsiella. Surgical prophylaxis, cellulitis, urinary infection. | 32 |
| Cephalosporins — 2nd generationcefotetan, cefoxitin, cefuroxime, cefprozil | covers | covers | partial | Both equally | More gram-negative activity than first generation — H. influenzae, Enterobacter, Neisseria, Proteus, E. coli, Klebsiella. | 33 |
| Cephalosporins — 3rd generationceftriaxone, ceftazidime, cefotaxime, cefdinir, cefixime | covers | covers | no | Both equally | Better gram-negative coverage than second generation, and loses more gram-positive. Adds Serratia and Moraxella catarrhalis. Ceftriaxone needs no renal adjustment but is avoided in the first 30 days of life. | 34 |
| Cephalosporins — 4th generationcefepime | covers | covers | no | Both equally | The exception to the trade-off: gram-negative activity WITHOUT sacrificing gram-positive. Antipseudomonal. No MRSA, no Enterococcus. | 36 |
| Cephalosporins — 5th generationceftaroline | covers | covers | no | Both equally | The cephalosporin with MRSA coverage. Gram-negative and gram-positive, no Enterococcus, no anaerobes. | 37 |
| Cephalosporins — 5th generationceftolozane/tazobactam | covers | covers | partial | Both equally | Antipseudomonal, with some anaerobic activity including Bacteroides. No MRSA, no Enterococcus. | 38 |
| Monobactamaztreonam | no | covers | no | Mainly gram-negative | Gram-negative ONLY. Spectrum resembles the aminoglycosides, with activity against P. aeruginosa. | 40 |
| Carbapenemsimipenem, meropenem, ertapenem | covers | covers | covers | Both equally | Very broad — gram-positive (not MRSA), gram-negative, anaerobes, and P. aeruginosa except ertapenem. | 43 |
| Vancomycinvancomycin | covers | no | no | Mainly gram-positive | Gram-positive ONLY. Drug of choice for MRSA and for penicillin-allergic infections. | 47 |
| Macrolidesazithromycin, clarithromycin, erythromycin | covers | covers | no | Both equally | Gram-positive and gram-negative aerobes, and the atypicals. Does not cover enterococci. | 55 |
| Tetracyclinestetracycline, doxycycline, minocycline | moderate | moderate | moderate | Both equally | Moderate across all three rather than strong anywhere — the only class the deck marks that way. Watch the calcium and iron binding, and photosensitivity. | 62 |
| Tigecyclinetigecycline | covers | covers | covers | Both equally | Broad across all three. Bacteriostatic, for complicated skin infection. | 65 |
| Aminoglycosidesgentamicin, tobramycin, amikacin | no | covers | no | Mainly gram-negative | Gram-negatives, including Pseudomonas and Enterobacter. No gram-positive coverage. The trough is checked to confirm it is undetectable. | 68 |
| Oxazolidinonelinezolid | covers | no | no | Mainly gram-positive | For vancomycin-resistant Enterococcus. Gram-positive only. | 72 |
| Fluoroquinolones — 2nd generationciprofloxacin | partial | covers | no | Mainly gram-negative | Gram-negative and atypical coverage, with variable Pseudomonas activity. Gram-positive cover is limited. | 76 |
| Fluoroquinolones — 3rd generationlevofloxacin | covers | covers | no | Both equally | Second-generation coverage with improved gram-positive activity, and it keeps Pseudomonas. Community-acquired pneumonia. | 77 |
| Fluoroquinolones — 3rd generationmoxifloxacin | covers | covers | no | Both equally | Second-generation coverage with improved gram-positive activity, but loses Pseudomonas. Community-acquired pneumonia. | 78 |
| Clindamycinclindamycin | covers | no | covers | Mainly gram-positive | Gram-positive aerobes including MRSA, and gram-positive anaerobes. It binds toxin, which is why it appears in toxic shock. | 80 |
| Sulfamethoxazole and trimethoprimsulfamethoxazole/trimethoprim | covers | covers | no | Both equally | Gram-positive aerobes including MRSA, and gram-negative aerobes. Does not cover enterococci. | 83 |
| Metronidazolemetronidazole | no | no | covers | Neither — anaerobes | Anaerobes only — gram-positive and gram-negative anaerobes. The alcohol interaction is its signature. | 86 |
| Polymyxinspolymyxin B, colistin (polymyxin E) | no | covers | no | Mainly gram-negative | Gram-negative only. A detergent-like mechanism against the lipopolysaccharide of the gram-negative outer membrane. | 87 |